Source: Eur Respir J 2013; 41: 243-245



Rating:

Share or cite this content

Citations should be made in the following way:
Hirota Takako, Fujita Masaki, Matsumoto Takemasa, Higuchi Takao, Shiraishi Takeshi, Minami Masato, Okumura Meinoshin, Nabeshima Kazuki, Watanabe Kentaro. Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection?. Eur Respir J 2013; 41: 243-245

Member's Comments

No comment yet.

Related content which might interest you: Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes Source: Eur Respir J 2012; 40: 377-385 Year: 2012 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation? Source: International Congress 2017 – ME10 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation? Year: 2017 Air-leak syndrome caused by pleuroparenchymal fibroelastosis after bone marrow transplantation Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 ME10 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation? Source: Milan 2017 - Educational material Year: 2017 Clinical and pathological features of idiopathic and secondary pleuroparenchymal fibroelastosis in patients undergoing lung transplantation Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Architectural remodelling in idiopathic interstitial pneumonias: fibrosis or fibroelastosis? Source: Eur Respir J 2004; 24: Suppl. 48, 557s Year: 2004 Atypical presentation of tuberculosis in chronic renal failure: a case mimicking lung carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 589s Year: 2003 Occult malignancy underlying a case of “hyperacute” onset of severe pulmonary hypertension Source: ERJ Open Res, 5 (4) 00157-2019; 10.1183/23120541.00157-2019 Year: 2019 Does emphysema coexistence with IPF change prognosis? Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Diffuse parenchymal lung diseases presenting with acute hypoxemic failure  Source: International Congress 2017 – Pulmonary emergencies year in review Year: 2017 Clues beyond the lung: an unusual diagnosis in an infant with chronic lung disease Source: Breathe, 16 (1) 190319; 10.1183/20734735.0319-2019 Year: 2020 Interstitial lung diseases in childhood Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=213 Year: 2002 Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019 Year: 2020 Never-smoking history as a poor prognostic factor in surgically proven idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease Source: Eur Respir J 2009; 33: 1498-1502 Year: 2009 Drug-induced infiltrative lung disease Source: Eur Respir Mon; 2009: 46: 287–318 Year: 2009 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016